{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:53:32Z","timestamp":1795020812237,"version":"4.10.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922040, 81930053, 81227901, 81971589, 81720108021 and 81527805"],"award-info":[{"award-number":["81922040, 81930053, 81227901, 81971589, 81720108021 and 81527805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7182109"],"award-info":[{"award-number":["7182109"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2019136, ZYQR201810117"],"award-info":[{"award-number":["2019136, ZYQR201810117"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Distant metastasis (DM) is the main cause of treatment failure in locally advanced rectal cancer. Adjuvant chemotherapy is usually used for distant control. However, not all patients can benefit from adjuvant chemotherapy, and particularly, some patients may even get worse outcomes after the treatment. We develop and validate an MRI-based radiomic signature (RS) for prediction of DM within a multicenter dataset. The RS is proved to be an independent prognostic factor as it not only demonstrates good accuracy for discriminating patients into high and low\u00a0risk of DM in all the four cohorts, but also outperforms clinical models. Within the stratified analysis, good chemotherapy efficacy is observed for patients with pN2 disease and low RS, whereas poor chemotherapy efficacy is detected in patients with pT1\u20132 or pN0 disease and high RS. The RS may help individualized treatment planning to select patients who may benefit from adjuvant chemotherapy for distant control.<\/jats:p>","DOI":"10.1038\/s41467-020-18162-9","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T10:04:31Z","timestamp":1598522671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":146,"title":["Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7559-8519","authenticated-orcid":false,"given":"Zhenyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankai","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4454-5005","authenticated-orcid":false,"given":"Meiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7772-7078","authenticated-orcid":false,"given":"Guoxiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0498-0432","authenticated-orcid":false,"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"18162_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","volume":"246","author":"Peeters KCMJ","year":"2007","unstructured":"Peeters KCMJ et al. The TME trial after a median follow-up of 6 years\u2014increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann. Surg. 246, 693\u2013701 (2007).","journal-title":"Ann. Surg."},{"key":"18162_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","volume":"373","author":"D Sebag-Montefiore","year":"2009","unstructured":"Sebag-Montefiore, D. et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373, 811\u2013820 (2009).","journal-title":"Lancet"},{"key":"18162_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","volume":"13","author":"C Rodel","year":"2012","unstructured":"Rodel, C. et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial. Lancet Oncol. 13, 679\u2013687 (2012).","journal-title":"Lancet Oncol."},{"key":"18162_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W van Gijn","year":"2011","unstructured":"van Gijn, W. et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 12, 575\u2013582 (2011).","journal-title":"Lancet Oncol."},{"key":"18162_CR5","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1200\/JCO.2013.54.3769","volume":"32","author":"E Fokas","year":"2014","unstructured":"Fokas, E. et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO\/ARO\/AIO-94 trial. J. Clin. Oncol. 32, 1554\u20131562 (2014).","journal-title":"J. Clin. Oncol."},{"key":"18162_CR6","doi-asserted-by":"publisher","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","volume":"29","author":"R Glynne-Jones","year":"2018","unstructured":"Glynne-Jones, R. et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 29, iv263 (2018).","journal-title":"Ann. Oncol."},{"key":"18162_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ijc.29355","volume":"137","author":"M Maas","year":"2015","unstructured":"Maas, M. et al. Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection A pooled analysis of 3,313 patients. Int. J. Cancer 137, 212\u2013220 (2015).","journal-title":"Int. J. Cancer"},{"key":"18162_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jamaoncol.2018.0231","volume":"4","author":"PM Polanco","year":"2018","unstructured":"Polanco, P. M., Mokdad, A. A., Zhu, H., Choti, M. A. & Huerta, S. Association of adjuvant chemotherapy with overall survival in patients with rectal cancer and pathologic complete response following neoadjuvant chemotherapy and resection. JAMA Oncol. 4, 938\u2013943 (2018).","journal-title":"JAMA Oncol."},{"key":"18162_CR9","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1200\/JCO.2010.33.1595","volume":"29","author":"V Valentini","year":"2011","unstructured":"Valentini, V. et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J. Clin. Oncol. 29, 3163\u20133172 (2011).","journal-title":"J. Clin. Oncol."},{"key":"18162_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J. Clin. 67, 93\u201399 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"18162_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/annonc\/mdw616","volume":"28","author":"UB Patel","year":"2017","unstructured":"Patel, U. B. et al. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial. Ann. Oncol. 28, 344\u2013353 (2017).","journal-title":"Ann. Oncol."},{"key":"18162_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/bjs.9419","volume":"101","author":"S Merkel","year":"2014","unstructured":"Merkel, S. et al. Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria. Br. J. Surg. 101, 566\u2013572 (2014).","journal-title":"Br. J. Surg."},{"key":"18162_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: images are more than pictures, they are data. Radiology 278, 563\u2013577 (2016).","journal-title":"Radiology"},{"key":"18162_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin, P. et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14, 749\u2013762 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"18162_CR15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.7150\/thno.30309","volume":"9","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges. Theranostics 9, 1303\u20131322 (2019).","journal-title":"Theranostics"},{"key":"18162_CR16","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang, Y. Q. et al. Development and validation of a radiomics nomogram for preoperative prediction of Lymph node metastasis in colorectal cancer. J. Clin. Oncol. 34, 2157\u20132164 (2016).","journal-title":"J. Clin. Oncol."},{"key":"18162_CR17","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1158\/1078-0432.CCR-17-1038","volume":"23","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin. Cancer Res. 23, 7253\u20137262 (2017).","journal-title":"Clin. Cancer Res."},{"key":"18162_CR18","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","volume":"25","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study. Clin. Cancer Res. 25, 3538\u20133547 (2019).","journal-title":"Clin. Cancer Res."},{"key":"18162_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1148\/radiol.2016152234","volume":"281","author":"YQ Huang","year":"2016","unstructured":"Huang, Y. Q. et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281, 947\u2013957 (2016).","journal-title":"Radiology"},{"key":"18162_CR20","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jamaoncol.2016.2631","volume":"2","author":"HJWL Aerts","year":"2016","unstructured":"Aerts, H. J. W. L. The potential of radiomic-based phenotyping in precisionmedicine a review. JAMA Oncol. 2, 1636\u20131642 (2016).","journal-title":"JAMA Oncol."},{"key":"18162_CR21","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1007\/s00330-018-5802-7","volume":"29","author":"HH Liu","year":"2019","unstructured":"Liu, H. H. et al. MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer. Eur. Radiol. 29, 4418\u20134426 (2019).","journal-title":"Eur. Radiol."},{"key":"18162_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis, J. R. & Koch, G. G. The measurement of observer agreement for categorical data. Biometrics 33, 159\u2013174 (1977).","journal-title":"Biometrics"},{"key":"18162_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/bjc.2015.260","volume":"113","author":"Y Pan","year":"2015","unstructured":"Pan, Y. et al. Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis. Br. J. Cancer 113, 763\u2013772 (2015).","journal-title":"Br. J. Cancer"},{"key":"18162_CR24","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1016\/j.ijrobp.2017.06.460","volume":"99","author":"J Wang","year":"2017","unstructured":"Wang, J., Shen, L., Zhong, H., Hu, P. & Zhang, Z. Radiomics prediction model for locally advanced rectal cancer. Int J. Radiat. Oncol. 99, S184\u2013S184 (2017).","journal-title":"Int J. Radiat. Oncol."},{"key":"18162_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00259-017-3855-5","volume":"45","author":"P Lovinfosse","year":"2018","unstructured":"Lovinfosse, P. et al. FDG PET\/CT radiomics for predicting the outcome of locally advanced rectal cancer. Eur. J. Nucl. Med Mol. Imaging 45, 365\u2013375 (2018).","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"18162_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jmri.25968","volume":"48","author":"YK Meng","year":"2018","unstructured":"Meng, Y. K. et al. Novel radiomic signature as a prognostic biomarker for locally advanced rectal cancer. J. Magn. Reson Imaging 48, 605\u2013614 (2018).","journal-title":"J. Magn. Reson Imaging"},{"key":"18162_CR27","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1158\/1078-0432.CCR-17-2507","volume":"24","author":"J Song","year":"2018","unstructured":"Song, J. et al. A new approach to predict progression-free survival in stage IV EGFR-mutant NSCLC patients with EGFR-TKI therapy. Clin. Cancer Res. 24, 3583\u20133592 (2018).","journal-title":"Clin. Cancer Res."},{"key":"18162_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.radonc.2018.11.007","volume":"132","author":"Z Tang","year":"2019","unstructured":"Tang, Z. et al. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer. Radiother. Oncol. 132, 100\u2013108 (2019).","journal-title":"Radiother. Oncol."},{"key":"18162_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00384-018-3181-9","volume":"34","author":"B Ma","year":"2019","unstructured":"Ma, B. et al. Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis. Int. J. Colorectal Dis. 34, 113\u2013121 (2019).","journal-title":"Int. J. Colorectal Dis."},{"key":"18162_CR30","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1158\/1078-0432.CCR-16-0702","volume":"22","author":"P Kickingereder","year":"2016","unstructured":"Kickingereder, P. et al. Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Clin. Cancer Res. 22, 5765\u20135771 (2016).","journal-title":"Clin. Cancer Res."},{"key":"18162_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ebiom.2018.09.007","volume":"36","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y. et al. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. EBioMedicine 36, 171\u2013182 (2018).","journal-title":"EBioMedicine"},{"key":"18162_CR32","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.7150\/thno.28018","volume":"8","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y. et al. Radiomic signature of (18)F fluorodeoxyglucose PET\/CT for prediction of gastric cancer survival and chemotherapeutic benefits. Theranostics 8, 5915\u20135928 (2018).","journal-title":"Theranostics"},{"key":"18162_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina, M. J., D\u2019Agostino, R. B., D\u2019Agostino, R. B. & Vasan, R. S. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat. Med. 27, 157\u2013172 (2008).","journal-title":"Stat. Med."},{"key":"18162_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/sim.4428","volume":"31","author":"MJ Pencina","year":"2012","unstructured":"Pencina, M. J., D\u2019Agostino, R. B. & Steyerberg, E. W. Comments on Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers\u2019 by M. J. Pencina, R. B. D\u2019Agostino, Sr. and E. W. Steyerberg reply. Stat. Med. 31, 96\u201397 (2012).","journal-title":"Stat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18162-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:45:39Z","timestamp":1670287539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18162-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["18162"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-18162-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4308"}}